Defining prostate cancer risk before prostate biopsy

被引：21

作者：

Pal, Raj P. ^{[1
]}

Maitra, Neil U. ^{[1
]}

Mellon, J. Kilian ^{[1
]}

Khan, Masood A. ^{[1
]}

机构：

[1] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Dept Urol, Leicester LE5 4PW, Leics, England

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2013年 / 31卷 / 08期

关键词：

Prostate cancer; Biopsy; Urine; Serum; Imaging; DIGITAL RECTAL EXAMINATION; MOLECULAR URINE ASSAY; COENZYME-A RACEMASE; TMPRSS2-ERG FUSION TRANSCRIPTS; ACID-PHOSPHATASE-ACTIVITY; METHYLACYL-COA RACEMASE; GLANDULAR KALLIKREIN 2; LONG-TERM PREDICTION; RADICAL PROSTATECTOMY; ANTIGEN PSA;

D O I：

10.1016/j.urolonc.2012.05.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Prostate cancer is the most commonly diagnosed cancer in men. At present, patients are selected for prostate biopsy on the basis of age, serum prostate specific antigen (PSA), and prostatic digital rectal examination (DRE) findings. However, due to limitations in the use of PSA and DRE, many patients undergo unnecessary prostate biopsy. A further problem arises as many patients are diagnosed and treated for indolent disease. This review of the literature highlights the strengths and weaknesses of existing methods of prebiopsy risk stratification and evaluates promising serum, urine, and radiologic prostate cancer biomarkers, which may improve risk stratification for prostate biopsy in the future. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：1408 / 1418

页数：11

共 50 条

[41] PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH AN INCREASED RISK OF ERECTILE DYSFUNCTION FOLLOWING PROSTATE BIOPSY
Helfand, Brian T.
Hedges, Jason C.
Cashy, John
McGuire, Barry B.
Catalona, William J.
McVary, Kevin T.
JOURNAL OF UROLOGY, 2011, 185 (04): : E724 - E724
[42] Can histological inflammation detected in a repeat prostate biopsy predict the risk of prostate cancer?
Dell'Atti, Lucio
MINERVA UROLOGICA E NEFROLOGICA, 2016, 68 (05) : 462 - 464
[43] PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH AN INCREASED RISK OF ERECTILE DYSFUNCTION FOLLOWING PROSTATE BIOPSY
Helfand, B. T.
Glaser, A. P.
Rimar, K.
Zargaroff, S.
Hedges, J.
McGuire, B. B.
Catalona, W. J.
McVary, K. T.
JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 213 - 214
[44] THE ASSOCIATION BETWEEN OXIDATIVE STRESS AND PROSTATE CANCER RISK IN MEN UNDERGOING PROSTATE BIOPSY
Barocas, Daniel
Motley, Saundra
Dai, Qi
Milne, Ginger
Morrow, Jason
Cookson, Michael
Smith, Joseph A., Jr.
Fowke, Jay
JOURNAL OF UROLOGY, 2010, 183 (04): : E794 - E794
[45] Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy
Helfand, Brian T.
Glaser, Alexander P.
Rimar, Kalen
Zargaroff, Sherwin
Hedges, Jason
McGuire, Barry B.
Catalona, William J.
McVary, Kevin T.
BJU INTERNATIONAL, 2013, 111 (01) : 38 - 43
[46] PROSTATE CANCER DIAGNOSIS IS ASSOCIATED WITH AN INCREASED RISK OF ERECTILE DYSFUNCTION FOLLOWING PROSTATE BIOPSY
Helfand, Brian
Hedges, Jason
Catalona, William
McVary, Kevin
JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 29 - 29
[47] Repeat Prostate Biopsy and the Incremental Risk of Clinically Insignificant Prostate Cancer EDITORIAL COMMENT
Jones, J. Stephen
UROLOGY, 2011, 77 (03) : 552 - 552
[48] Does an Inflammatory Pattern at Primary Biopsy Suggest a Lower Risk for Prostate Cancer at Repeated Saturation Prostate Biopsy?
Pepe, Pietro
Aragona, Francesco
UROLOGIA INTERNATIONALIS, 2011, 87 (02) : 171 - 174
[49] Predictive Value of Hormonal Evaluation Before Prostate Needle Biopsy on Prostate Cancer T Stage and Prognosis
Celik, Serdar
Bozkurt, Ozan
Yildiz, Huseyin Alperen
Demir, Omer
Tuna, Burcin
Yorukoglu, Kutsal
Aslan, Guven
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2018, 17 (01): : 9 - 13
[50] Performance of Prostate Cancer Prevention Trial Risk Calculator in a Contemporary Cohort Screened for Prostate Cancer and Diagnosed by Extended Prostate Biopsy
Nguyen, Carvell T.
Yu, Changhong
Moussa, Ayman
Kattan, Michael W.
Jones, J. Stephen
JOURNAL OF UROLOGY, 2010, 183 (02): : 529 - 533

← 1 2 3 4 5 →